title: Cutaneous graft-versus-host disease: rationales and treatment options.
abstract: The treatment of cutaneous graft-versus-host disease (GVHD) is one of the most challenging clinical scenarios in a dermatological practice. Given the significant risk of morbidity and mortality in this patient group, it is important for a dermatologist to understand the pathophysiology of GVHD, as well as their role within a multidisciplinary practice where many immunosuppressants are prescribed. A significant proportion of the patients with GVHD will require a combination treatment regimen in order to stem the progression of their disease. In this review, the stages, type of GVHD and treatment options are reviewed for the dermatologist.
authors.affiliation: Department of Dermatology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
authors.forename: Rahul
authors.initials: R
authors.lastname: Chavan
authors.forename: Rokea
authors.initials: R
authors.lastname: el-Azhary
mesh_terms: D000208:Acute Disease; D002908:Chronic Disease; D006086:Graft vs Host Disease / Q000145:classification / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D006801:Humans; D012867:Skin / Q000473:pathology; D012871:Skin Diseases / Q000145:classification / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy*; D016896:Treatment Outcome